Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We would all like to wish Prof Kevin Gatter good luck for the future as he retires from University service at the end of this month.

Photo of Prof Kevin Gatter
Prof Kevin Gatter

Kevin became Head of the Department of Cellular Science, when it spun out of the Nuffield Department of Pathology over two decades ago. He then led the Department through mergers with Clinical Biochemistry and the Nuffield Department of Pathology to create NDCLS, which is now a Division within RDM. Kevin was clinically active throughout his career and is an internationally recognised expert in haematopathology. Kevin made seminal research contributions to the development of immunohistochemistry and to the classification of lymphomas, later pursuing an interest in angiogenesis. He was recognised by ISI Thompson Scientific as one of the most highly cited and influential researchers in his field.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Enterprise Associate Interview with Dr Shilpa Nagarajan

Dr Shilpa Nagarajan is one of the MPLS Enterprise and Innovation Fellows for 2022-23.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life

The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.

Wellcome Trust funding success for Jim Hughes and James Davies

£3.6 million in funding awarded by the Wellcome Trust to combine cutting-edge 3D genome technologies with machine learning approaches to decipher the role of the non-coding genome in disease.

Fundraising for award in memory of Dr Ling Felce

The Ling Felce award will promote cross-disciplinary excellence in bioinformatics.